Advertisement

Pediatric Cannabis Single-Substance Exposures Reported to the Michigan Poison Center From 2008–2019 After Medical Marijuana Legalization

Published:February 02, 2021DOI:https://doi.org/10.1016/j.jemermed.2020.12.028

      Abstract

      Background

      Legalization of medical and recreational cannabis is a major contributor to pediatric cannabis exposures. The trends and magnitude of pediatric cannabis exposures in Michigan after medical cannabis legalization in 2008 have not been assessed.

      Objective

      To describe the temporal trends of pediatric cannabis exposures reported to the Michigan Poison Center (MiPC) after medical cannabis was legalized in 2008 and 1 year after legalization of recreational cannabis in 2018.

      Methods

      Retrospective electronic chart review of pediatric (<18 years old) single-substance cannabis exposures reported to the MiPC from January 1, 2008 to December 31, 2019. Routes of cannabis exposure were reported as ingestion, inhalation, and unknown. Types of ingested cannabis products were also documented.

      Results

      Between 2008 and 2019, 426 pediatric cannabis single exposures were reported. The median patient age was 6.0 years (interquartile range 2–15 years). Age distribution was bimodal. A total of 327 (76.8%) exposures were from cannabis ingestion, 79 (18.5%) from inhalation, 2 (0.5%) from both ingestion and inhalation, and 18 (4.2%) from unknown route. The doubling time for number of cases was 2.1 years, and the total number of annual reported cases increased after 2016. Teenagers (13–17 years) had the highest number of inhalational exposures, whereas young children (0–5 years) had the highest number of ingestions.

      Conclusion

      Single-substance pediatric cannabis exposures reported to the Michigan Poison Center increased after medical cannabis was legalized in 2008 through recreational legalization in 2018.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Substance Abuse and Mental Health Services Administration (SAMHSA)
        Results from the 2018 National Survey on Drug Use and Health.
        (Available at:)
        • Centers for Disease Control and Prevention (CDC)
        1991-2017 High School Youth Risk Behavior Survey.
        (Available at:)
        • U.S. Drug Enforcement Agency
        Drug scheduling.
        (Available at:)
        https://www.dea.gov/drug-scheduling
        Date accessed: May 5, 2020
        • Ballotpedia
        2020 marijuana legalization and marijuana-related ballot measures.
        (Available at:)
        • Wang G.S.
        • Roosevelt G.
        • Le Lait M.C.
        • et al.
        Association of unintentional pediatric exposures with decriminalization of marijuana in the United States.
        Ann Emerg Med. 2014; 63: 684-689
        • Drug Abuse Warning Network (DAWN), Substance Abuse and Mental Health Services Administration (SAMHSA)
        Highlights of the 2011 DAWN findings on drug-related emergency department visits.
        (Available at:)
        • Whitehill J.M.
        • Harrington C.
        • Lang C.J.
        • Chary M.
        • Bhutta W.A.
        • Burns M.M.
        Incidence of pediatric cannabis exposure among children and teenagers aged 0 to 19 years before and after medical marijuana legalization in Massachusetts.
        JAMA Netw Open. 2019; 2: e199456
        • Thomas A.A.
        • Von Derau K.
        • Bradford M.C.
        • Moser E.
        • Garrard A.
        • Mazor S.
        Unintentional pediatric marijuana exposures prior to and after legalization and commercial availability of recreational marijuana in Washington State.
        J Emerg Med. 2019; 56: 398-404
        • Wang G.S.
        • Le Lait M.C.
        • Deakyne S.J.
        • Bronstein A.C.
        • Bajaj L.
        • Roosevelt G.
        Unintentional pediatric exposures to marijuana in Colorado, 2009–2015.
        JAMA Pediatr. 2016; 170: e160971
        • Wang G.S.
        • Hall K.
        • Vigil D.
        • Banerji S.
        • Monte A.
        • VanDyke M.
        Marijuana and acute health care contacts in Colorado.
        Prev Med. 2017; 104: 24-30
        • Hasin D.S.
        US epidemiology of cannabis use and associated problems.
        Neuropsychopharmacology. 2018; 43: 195-212
        • Johnson J.
        • Hodgkin D.
        • Harris S.K.
        The design of medical marijuana laws and adolescent use and heavy use of marijuana: analysis of 45 states from 1991 to 2011.
        Drug Alcohol Depend. 2017; 170: 1-8
        • Hasin D.S.
        • Wall M.
        • Keyes K.M.
        • et al.
        Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys.
        Lancet Psychiatry. 2015; 2: 601-608
        • Wang G.S.
        • Davies S.D.
        • Halmo L.S.
        • Sass A.
        • Mistry R.D.
        Impact of marijuana legalization in Colorado on adolescent emergency and urgent care visits.
        J Adolesc Health. 2018; 63: 239-241
        • Wang G.S.
        • Hoyte C.
        • Roosevelt G.
        • Heard K.
        The continued impact of marijuana legalization on unintentional pediatric exposures in Colorado.
        Clin Pediatr (Phila). 2019; 58: 114-116
        • Marijuana Regulatory Agency
        Adult-use marihuana establishments: Emergency Rules. State of Michigan Department of Licensing and Regulatory Affairs.
        (Available at:)
        • Colorado Department of Revenue
        Marijuana tax data.
        (Available at:)
        • Marijuana Regulatory Agency
        Monthly report: March 2020. State of Michigan Department of Licensing and Regulatory Affairs.
        (Available at:)
        • Marijuana Regulatory Agency
        Monthly report: April 2020. State of Michigan Department of Licensing and Regulatory Affairs.
        (Available at:)
        • Ammerman S.
        • Ryan S.
        • Adelman W.P.
        • Committee on Substance Abuse, the Committee on Adolescence
        The impact of marijuana policies on youth: clinical, research, and legal update.
        Pediatrics. 2015; 135: e769-e785
      1. NORML. State laws.
        (Available at:)
        https://norml.org/states
        Date accessed: April 17, 2020
        • Hoffman R.S.
        Understanding the limitations of retrospective analyses of poison center data.
        Clin Toxicol (Phila). 2007; 45: 943-945